Piedmont Capital Management (Montana)’s Pfizer PFE Stock Holding History

Piedmont Capital Management (Montana)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,567	Closed	-$384K	–	49
2023 Q3	$384K	Buy	11,567 +1,751	+18%	+$61.9K	0.31%	37
2023 Q2	$360K	Sell	9,816 -1,576	-14%	-$61.3K	0.27%	38
2023 Q1	$460K	Sell	11,392 -399	-3%	-$17.2K	0.37%	38
2022 Q4	$604K	Sell	11,791 -86	-0.7%	-$4.12K	0.51%	27
2022 Q3	$525K	Sell	11,877 -1,736	-13%	-$84.4K	0.47%	26
2022 Q2	$712K	Sell	13,613 -1,174	-8%	-$59.8K	0.73%	22
2022 Q1	$769K	Sell	14,787 -3,215	-18%	-$167K	0.58%	25
2021 Q4	$1.06M	Buy	18,002 +147	+0.8%	+$7.28K	0.84%	18
2021 Q3	$768K	Sell	17,855 -1,521	-8%	-$67.4K	0.61%	23
2021 Q2	$765K	Sell	19,376 -3,572	-16%	-$139K	0.64%	21
2021 Q1	$829K	Buy	22,948 +2,121	+10%	+$75.3K	0.78%	20
2020 Q4	$767K	Buy	+20,827	New	+$764K	0.78%	16

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Piedmont Capital Management (Montana)'s PFE Position: Q4 2023 in Review

Piedmont Capital Management (Montana) sold out of Pfizer (PFE) in Q4 2023, closing a stake of 11,567 shares — an estimated $384K sold.

Piedmont Capital Management (Montana) first reported a position in PFE in Q4 2020 and held it in 12 quarters. The position peaked at $1.06M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Piedmont Capital Management (Montana) reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Piedmont Capital Management (Montana) sold 11,567 Pfizer shares in Q4 2023, an estimated $384K.
Piedmont Capital Management (Montana) first reported a position in Pfizer in Q4 2020 and held it in 12 quarters.
Piedmont Capital Management (Montana)'s Pfizer position peaked at $1.06M in Q4 2021.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Piedmont Capital Management (Montana)'s 13F filing for Q4 2023, filed 13 Feb 2024.